Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBT (2016 - 2018)

Historic EBT for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$1.1 million.

  • Armata Pharmaceuticals' EBT rose 5318.88% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$9.4 million, marking a year-over-year increase of 3411.67%. This contributed to the annual value of -$53.2 million for FY2024, which is 2270.81% down from last year.
  • As of Q4 2018, Armata Pharmaceuticals' EBT stood at -$1.1 million, which was up 5318.88% from -$2.8 million recorded in Q3 2018.
  • Armata Pharmaceuticals' EBT's 5-year high stood at -$779000.0 during Q3 2017, with a 5-year trough of -$11.3 million in Q1 2014.
  • Its 5-year average for EBT is -$4.0 million, with a median of -$2.9 million in 2015.
  • As far as peak fluctuations go, Armata Pharmaceuticals' EBT tumbled by 69125.26% in 2014, and later skyrocketed by 7661.1% in 2017.
  • Over the past 5 years, Armata Pharmaceuticals' EBT (Quarter) stood at -$2.6 million in 2014, then fell by 13.21% to -$2.9 million in 2015, then tumbled by 242.04% to -$10.1 million in 2016, then skyrocketed by 76.61% to -$2.4 million in 2017, then skyrocketed by 53.19% to -$1.1 million in 2018.
  • Its EBT was -$1.1 million in Q4 2018, compared to -$2.8 million in Q3 2018 and -$3.2 million in Q2 2018.